The neuropeptide galanin (GAL) has a widespread distribution throughou
t the human cortex. The entorhinal cortex (ENT) plays a crucial role i
n the transfer of cortico-cortical information related to memory and d
isplays severe degeneration in Alzheimer's disease (AD). However, very
little is known about the pharmacology of the GAL receptor (GALR) in
normal human ENT. Therefore, we pharmacologically visualized their dis
tribution and characterized GALRs using in vitro receptor autoradiogra
phy and radioligand binding assays. Autoradiograms revealed intense GA
LR labeling, mainly in the substantia innominata, hypothalamus, the be
d nucleus of the stria Its terminalis and within layers 2 and 4 of the
ENT. Kinetic experiments showed that saturation of GALR sites by [I-1
25]GAL (human) (hGAL) occurred within 2 h and that this binding readil
y reversed in the presence of a GTP analog, but not in the presence of
excess unlabeled hGAL. Analysis of [I-125]hGAL binding data from satu
ration experiments gave K-D values of 98.6+/-21.6 pM, B-max values of
52.9+/-32.4 fmol/mg protein and identified a high and low affinity sta
te of the GALR. The presence of 5'-guanylylimidodiphosphate (GppNHp) o
r NaCl reduced the agonist labeling of hGALR in ENT membranes. (C) 199
8 Elsevier Science B.V.